Low adiponectin levels have also been linked to an increased risk of developing type 2 diabetes, metabolic syndrome, insulin resistance, hypertension, cardiovascular disease, and different malignancies, including breast cancer (59). This evidence concerns the gene ADIPOQ and breast cancer.